Xing Mm Xing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xing Mm Xing has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Chun Bm Zuo
Neurological Intensive Care Unit, Hebei General Hospital, Shijiazhuang, China
1 shared publication - Hongshan Chu
Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei Province, China
1 shared publication - Hongyu Hao
Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei Province, China
1 shared publication - Jin An
Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei Province, China
1 shared publication Lei Mm Zhao
Neurological Intensive Care Unit, Hebei General Hospital, Shijiazhuang, China
1 shared publicationMingmin Bm Zhao
Neurological Intensive Care Unit, Hebei General Hospital, Shijiazhuang, China
1 shared publication
Latest Publications
- Open Access
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e45493
Effect of pre-stroke statin use on the progression of intracranial atherosclerosis in ischemic stroke patients: Evidence from high-resolution magnetic resonance imaging
High-resolution magnetic resonance imaging (HR-MRI) has emerged as a valuable tool for evaluating intracranial atherosclerotic plaque characteristics in vivo. This study aimed to identify clinical and imaging predictors of plaque enhancement (PE) on HR-MRI in patients presenting with acute ischemic stroke (AIS) or transient ischemic attack (TIA). We retrospectively included consecutive patients diagnosed with AIS or TIA who underwent HR-MRI between January 2021 and August 2022. Participants were categorized according to the presence or absence of contrast enhancement in culprit plaques and further stratified by prior statin usage. Plaque enhancement was defined as increased signal intensity on contrast-enhanced T1-weighted images. Clinical profiles and imaging parameters were compared between groups. Among the 208 participants, 138 demonstrated enhancement of the culprit plaque, whereas 70 showed no such enhancement. Enhanced plaques were associated with significantly greater plaque burden and higher degrees of luminal stenosis (both P < .001). At the site of maximum stenosis, patients without enhancement exhibited significantly larger vessel area (VA; P = .01) and lumen area (LA; P < .001). A modest but statistically significant correlation was observed between stenosis severity and enhancement grade (Spearman ρ = 0.372, P < .001). Notably, prior use of statins was associated with a lower incidence of PE ( P = .03). HR-MRI–detected PE is associated with more severe arterial narrowing and may serve as an indicator of plaque instability. The observed reduction in enhancement among statin users supports the potential role of statin therapy in stabilizing intracranial atherosclerotic lesions.
- 26 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (52) , e45493
Open AccessEffect of pre-stroke statin use on the progression of intracranial atherosclerosis in ischemic stroke patients: Evidence from high-resolution magnetic resonance imaging
High-resolution magnetic resonance imaging (HR-MRI) has emerged as a valuable tool for evaluating intracranial atherosclerotic plaque characteristics in vivo. This study aimed to identify clinical and imaging predictors of plaque enhancement (PE) on HR-MRI in patients presenting with acute ischemic stroke (AIS) or transient ischemic attack (TIA). We retrospectively included consecutive patients diagnosed with AIS or TIA who underwent HR-MRI between January 2021 and August 2022. Participants were categorized according to the presence or absence of contrast enhancement in culprit plaques and further stratified by prior statin usage. Plaque enhancement was defined as increased signal intensity on contrast-enhanced T1-weighted images. Clinical profiles and imaging parameters were compared between groups. Among the 208 participants, 138 demonstrated enhancement of the culprit plaque, whereas 70 showed no such enhancement. Enhanced plaques were associated with significantly greater plaque burden and higher degrees of luminal stenosis (both P < .001). At the site of maximum stenosis, patients without enhancement exhibited significantly larger vessel area (VA; P = .01) and lumen area (LA; P < .001). A modest but statistically significant correlation was observed between stenosis severity and enhancement grade (Spearman ρ = 0.372, P < .001). Notably, prior use of statins was associated with a lower incidence of PE ( P = .03). HR-MRI–detected PE is associated with more severe arterial narrowing and may serve as an indicator of plaque instability. The observed reduction in enhancement among statin users supports the potential role of statin therapy in stabilizing intracranial atherosclerotic lesions.
- Open Access
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e34409
Case report: Lateral medullary syndrome with eight-and-a-half syndromes
Rationale: Lateral medullary syndrome is caused by atherosclerosis or embolism of the vertebral artery and its branches or the posterior inferior cerebellar artery (PICA).The eight-and-a-half syndrome is a rare pontocerebellar nerve-ocular syndrome presenting as a one-and-a-half syndrome plus ipsilateral seventh cerebral nerve palsy. The dorsolateral medullary syndrome combined with the eight-and-a-half syndromes is even rarer, so it is important to recognize the features of the classical brainstem syndrome and the eight-and-a-half syndromes. Patient concerns: Most patients with dorsolateral medullary syndrome combined with eight-and-a-half syndromes have a good prognosis, with recovery occurring within a few weeks to a few months, although a few patients may take longer to recover. Diagnosis interventions: In the course of disease development, the patient developed dysarthria, dysphagia, hypothermia, ipsilateral Horner sign and ataxia. Computed tomography was performed which showed cerebral infarction in the left brainstem. Cranial diffusion-weighted imaging + magnetic resonance angiography showed acute infarction in the left cerebellar hemisphere, with a high probability of severe stenosis or occlusion in the intracranial and proximal segments of the basilar arteries. This supports the diagnosis of dorsolateral medullary syndrome. The patient’s limited adduction and abduction of the left eye and limited adduction of the right eye, combined with peripheral paralysis of the affected lateral nerve, supported the diagnosis of eight-and-a-half syndromes. The administration of antiplatelet and anti-ester fixation treatment can effectively improve the symptoms and shorten the course of the disease. Outcomes: After antiplatelet and anti-ester fixation treatment, the symptoms improved and the patient was discharged. Lessons: Dorsolateral medullary syndrome combined with eight-and-a-half syndromes is a rare clinical condition, and therefore more attention should be paid to the early diagnosis and treatment of such patients.
- 9 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (6) , e34409
Open AccessCase report: Lateral medullary syndrome with eight-and-a-half syndromes
Rationale: Lateral medullary syndrome is caused by atherosclerosis or embolism of the vertebral artery and its branches or the posterior inferior cerebellar artery (PICA).The eight-and-a-half syndrome is a rare pontocerebellar nerve-ocular syndrome presenting as a one-and-a-half syndrome plus ipsilateral seventh cerebral nerve palsy. The dorsolateral medullary syndrome combined with the eight-and-a-half syndromes is even rarer, so it is important to recognize the features of the classical brainstem syndrome and the eight-and-a-half syndromes. Patient concerns: Most patients with dorsolateral medullary syndrome combined with eight-and-a-half syndromes have a good prognosis, with recovery occurring within a few weeks to a few months, although a few patients may take longer to recover. Diagnosis interventions: In the course of disease development, the patient developed dysarthria, dysphagia, hypothermia, ipsilateral Horner sign and ataxia. Computed tomography was performed which showed cerebral infarction in the left brainstem. Cranial diffusion-weighted imaging + magnetic resonance angiography showed acute infarction in the left cerebellar hemisphere, with a high probability of severe stenosis or occlusion in the intracranial and proximal segments of the basilar arteries. This supports the diagnosis of dorsolateral medullary syndrome. The patient’s limited adduction and abduction of the left eye and limited adduction of the right eye, combined with peripheral paralysis of the affected lateral nerve, supported the diagnosis of eight-and-a-half syndromes. The administration of antiplatelet and anti-ester fixation treatment can effectively improve the symptoms and shorten the course of the disease. Outcomes: After antiplatelet and anti-ester fixation treatment, the symptoms improved and the patient was discharged. Lessons: Dorsolateral medullary syndrome combined with eight-and-a-half syndromes is a rare clinical condition, and therefore more attention should be paid to the early diagnosis and treatment of such patients.